fbpx

Numan, the online health clinic for men, has completed a £10M Series A funding round, to continue building the future of health in collaboration with its patients.

The round was led by the legal firm Novator Partners, along with investors, Anthemis Exponential, Vostok New Ventures, and Colle Capital.

Launched in February 2019, Numan helps men take action when it comes to their health and wellbeing, with quick and convenient access to clinical advice online. The company provides regulated treatment options for the most
common male health concerns, with a team of clinicians who can create personalised treatment plans online.

Sokratis Papafloratos, CEO and Founder, Numan, said, “We are building a new kind of healthcare company that gives men simple and accessible solutions for their health and wellbeing problems.

“We help men understand their health better through a series of diagnostics and clinician consultations, and offer medical solutions that cover everything all via a comprehensive digital health platform. We look forward to becoming a holistic health partner for them, backed by a world-class team of investors.”

As part of the funding, Birgir Már Ragnarsson from Novator Partners joins Numan’s Board of Directors. Ragnarsson said, “We were impressed with Numan’s capital-efficient execution so far and are excited about the future direction of the company. Health is one of the largest economic transformation opportunities still addressable at a global scale, and we’re delighted to be part of Numan’s journey.”

Numan intends to use the funds to develop new ways of providing men with access to clinical advice and treatment.
As part of its growth plan, the company is also developing its own IP around digital health but is also in a number of partnership conversations that can extend and expand the therapeutic model on offer.

Sam Shah, Chief Medical Strategy Officer said: “I decided to join Numan because of the company’s strong and sincere commitment to developing citizen-centric health services. It’s great to work with a team that is committed to developing health technology that will help people improve their wellbeing, and this funding will enable us to continue investing in new disease areas and technology to make healthcare even more accessible via digital channels.”